At the high-level conference, “Dialogue for Children: Central Asia and UNICEF,” held recently in Tashkent, the health ministers of Kazakhstan and Uzbekistan met to expand bilateral cooperation in healthcare.
Kazakhstan’s Health Minister Akmaral Alnazarova and her Uzbek counterpart Asilbek Khudayarov discussed a range of initiatives aimed at enhancing the quality of medical services in both countries. According to the Uzbek Health Ministry, the discussions focused on joint research projects, the exchange of medical expertise, and collaboration within the coalition of countries supporting primary healthcare. The two sides also considered conducting environmental studies in the Aral Sea region to assess the health impacts of local ecological conditions.
Focus on Pediatric Health and Cancer Treatment
Children’s health emerged as a central theme in the talks. Kazakhstan proposed establishing an international academic hub for childhood cancer and offered to take the lead on the initiative.
Minister Alnazarova outlined Kazakhstan’s use of advanced diagnostic and treatment methods for pediatric cancer, including immunohistochemistry, immunophenotyping, tumor marker detection, high-dose chemotherapy for bone and soft tissue sarcomas, and organ-preserving surgeries. She also announced that a new Proton Therapy Center will open in Astana this October. The center is expected to treat over 800 patients annually and will offer radioiodine therapy for children from across Central Asia.
Kazakhstan also proposed creating two additional international hubs: one for adult oncology and oncohematology, and another for pediatric heart surgery at the UMC Heart Center. The heart surgery hub would be open to patients from Uzbekistan, including children from Karakalpakstan.
Alnazarova noted that several areas of Kazakhstan’s healthcare system now meet international standards, with hospitals adopting globally recognized technologies and practices.
Expanding Bilateral Healthcare Ties
To deepen bilateral engagement, the two ministers agreed to hold “Kazakhstan Medicine Days” in Uzbekistan in 2025, followed by “Uzbekistan Medicine Days” in Kazakhstan in 2026. They also endorsed the creation of an international healthcare hub to promote cross-border collaboration.
In a related development, Kazakhstan’s Minister of Science and Higher Education, Sayasat Nurbek, announced in March that the country is developing a new anti-cancer drug. Phase II clinical trials, completed last year, showed promising results, including an average tumor size reduction of 30%. The drug is expected to be registered and released to the market by the end of 2024.
